EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence for Computer-Aided Drug Discovery

Aditya Kate, Ekkita Seth, Ananya Singh, Chandrashekhar Mahadeo Chakole, Meenakshi Kanwar Chauhan, Ravi Kant Singh, Shrirang Maddalwar, Mohit Mishra iD

Drug Research · 01.09.2023 · 73 (07) · 369-377

DOI: 10.1055/a-2076-3359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.09.2023. Verfasst von Aditya Kate und 7 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University, Chhattisgarh, India. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Discovery. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuous implementation of Artificial Intelligence (AI) in multiple scientific domains and the rapid advancement in computer software and hardware, along with other parameters, have rapidly fuelled this development. The technology can contribute effectively in solving many challenges and constraints in the traditional development of the drug. Traditionally, large-scale chemical libraries are screened to find one promising medicine. In recent years, more reasonable structure-based drug design approaches have avoided the first screening phases while still requiring chemists to design, synthesize, and test a wide range of compounds to produce possible novel medications. The process of turning a promising chemical into a medicinal candidate can be expensive and time-consuming. Additionally, a new medication candidate may still fail in clinical trials even after demonstrating promise in laboratory research. In fact, less than 10% of medication candidates that undergo Phase I trials really reach the market. As a consequence, the unmatched data processing power of AI systems may expedite and enhance the drug development process in four different ways: by opening up links to novel biological systems, superior or distinctive chemistry, greater success rates, and faster and less expensive innovation trials. Since these technologies may be used to address a variety of discovery scenarios and biological targets, it is essential to comprehend and distinguish between use cases. As a result, we have emphasized how AI may be used in a variety of areas of the pharmaceutical sciences, including in-depth opportunities for drug research and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDrug DiscoveryDrug DesignSoftwareComputers

Autor:innen und Institutionen

  • Amity Institute of Biotechnology, Amity University, Chhattisgarh, India.
  • Bajiraoji Karanjekar college of Pharmacy, Sakoli, Dist-Bhandara, India.
  • NDDS Research Lab, Delhi Institute of Pharmaceutical Sciences and Research, DPSR-University, New Delhi.
  • Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India.

ORCID-Profile: Mohit Mishra

Zitieren

APA

Kate, A., Seth, E., Singh, A., Chakole, C. M., Chauhan, M. K., Singh, R. K., Maddalwar, S., & Mishra, M. (2023). Artificial Intelligence for Computer-Aided Drug Discovery. Drug Research, 73(07), 369-377. https://doi.org/10.1055/a-2076-3359

Vancouver

Kate A, Seth E, Singh A, Chakole CM, Chauhan MK, Singh RK, et al. Artificial Intelligence for Computer-Aided Drug Discovery. Drug Research. 2023;73(07):369-377. doi:10.1055/a-2076-3359

BibTeX
@article{Kate2023,
  author = {Kate, Aditya and Seth, Ekkita and Singh, Ananya and Chakole, Chandrashekhar Mahadeo and Chauhan, Meenakshi Kanwar and Singh, Ravi Kant and Maddalwar, Shrirang and Mishra, Mohit},
  title = {Artificial Intelligence for Computer-Aided Drug Discovery},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {07},
  pages = {369--377},
  doi = {10.1055/a-2076-3359}
}
Kostenlos starten →